title: [Case of meningitis caused by group B Streptococcus treated with high dose of meropenem].
abstract: We reported a case of meningitis caused by group B Streptococcus treated with high dose of meropenem (MEPM). A 67-year-old male was suffering from lumbago, fever up, vomiting and convulsion. He had received tumor resection of spinal cord at 40 years old. At the first consultation to our hospital, he had felt strong neck stiffness with Glasgow Coma Scale 5 (El, V1, M3), and his body temperature was 37.0 degrees C. His laboratory findings were as follows; white blood cell count 14600/microL, C-reactive protein 4.39mg/dL, and marked elevation of the cell count in the cerebrospinal fluid. We had administered high dose of meropenem, 6 g/day, and also vancomycin (VCM) on therapeutic drug monitoring. Since his clinical symptoms and laboratory findings had not shown adequate response after 4 days later, we had changed VCM to linezolid 1200 mg/day, and had also continued MEPM, which had resulted in prompt resolution of the clinical symptoms and laboratory findings. Microbiological examination for cerebrospinal fluid has yielded a growth of serotype III group B Streptococcus (Streptococcus agalactiae). Since there have been few data on 6 g/day MEPM against meningitis in spite of recommendation in several guidelines, further studies would be necessary including pharmacokinetic-pharmacodynamic analysis.
authors: Department of Infection Control and Prevention, Aichi Medical University Graduate School of Medicine.
authors: Yuka
authors: Y
authors: Yamagishi
authors: Hiroshige
authors: H
authors: Mikamo
mesh_terms: D000081:Acetamides / Q000008:administration & dosage; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D006801:Humans; D000069349:Linezolid; D008297:Male; D016920:Meningitis, Bacterial / Q000188:drug therapy* / Q000382:microbiology*; D000077731:Meropenem; D023303:Oxazolidinones / Q000008:administration & dosage; D020551:Pulse Therapy, Drug; D012703:Serotyping; D013290:Streptococcal Infections; D013292:Streptococcus agalactiae / Q000145:classification / Q000302:isolation & purification; D013845:Thienamycins / Q000008:administration & dosage*; D016896:Treatment Outcome; D014640:Vancomycin / Q000008:administration & dosage
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D023303:Oxazolidinones; D013845:Thienamycins; D014640:Vancomycin; D000077731:Meropenem; D000069349:Linezolid